Licensor:

European biotech

Licensee:

Asian Pharmaceutical company

Product:

Small molecule recently launched in Western markets

Therap. Area:

Oncology

Situation:

Licensing rights for certain Asian territories had been recovered from previous global licensee. A new, reliable and diligent development partner for Asia had to be identified urgently.

Objectives:

Find the right partner for the respective Asian territories who makes the necessary investment in a timely manner and who appropriately values such license.

Activities:

After the suitable partner had been identified, a complex negotiation process could be driven to a very satisfactory result.

Results:

• Licensing, development and commercialization agreement signed. The new partner accepted appropriate performance clauses.
• Upfront and early milestone payments contributed significantly to the licensor’s balance sheet.
• The licensee is currently developing the compound in his territory with great success, generating outstanding clinical data.